✦ LIBER ✦

Anti-cachectic Effect of FK317, a Novel Anti-cancer Agent, in Colon26 and LX-1 Models in Mice

✍ Scribed by Naoe, Yoshinori ;Kawamura, Ikuo ;Inami, Masamichi ;Matsumoto, Sanae ;Nishigaki, Fusako ;Tsujimoto, Susumu ;Manda, Toshitaka ;Shimomura, Kyoichi

Book ID: 108581552
Publisher: Wiley (Blackwell Publishing)
Year: 1998
Tongue: English
Weight: 133 KB
Volume: 89
Category: Article
ISSN: 0910-5050
DOI: 10.1111/j.1349-7006.1998.tb00529.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of FK317, a novel anti-cancer ag

Effects of FK317, a novel anti-cancer agent, on survival of mice bearing B16BL6 melanoma and Lewis lung carcinoma

✍ Masamichi Inami; Ikuo Kawamura; Susumu Tsujimoto; Fusako Nishigaki; Sanae Matsum 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Therapeutic effect of a novel anti-parki

Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)neurotoxicity in mice

✍ Hironori Yokoyama; Ryohei Yano; Hayato Kuroiwa; Tatsuya Tsukada; Hiroto Uchida; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 523 KB

Therapeutic effect of a novel anti-parki

Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) neurotoxicity in mice

✍ Hironori Yokoyama; Ryohei Yano; Hayato Kuroiwa; Tatsuya Tsukada; Hiroto Uchida; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 527 KB

Effect of TOK-8801, a novel immunomodula

Effect of TOK-8801, a novel immunomodulating agent, on the in vivo anti-SRBC PFC response in mice

✍ T. Kobayashi; K. Shibata; M. Fujiwara; N. Takayanagi; K. Matsunari; K. Nitta; I. 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Erratum: Therapeutic effect of a novel a

Erratum: Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) neurotoxicity in mice

✍ Hironori Yokoyama; Ryohei Yano; Hayato Kuroiwa; Tatsuya Tsukada; Hiroto Uchida; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 52 KB

226 POSTER Preclinical pharmacokinetic,

226 POSTER Preclinical pharmacokinetic, tissue distribution, and metabolism studies of RTA 402 (CDDO-ME), a novel agent with anti-cancer and anti-inflammatory activities in phase 1 development

✍ C. Meyer; R. Abrahams 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 149 KB